FOXP3 and neoplasm: In some studies, the density of FOXP3+ tumor-infiltrating cells correlated positively with a prolonged patient survival [167,169], and accordingly, stage II CRC patients with poor CD3+ and FOXP3+ infiltration presented a higher risk of tumor progression [170].